Sign in
4

Changes in Ownership

Tonix Pharmaceuticals Holding Corp. Filed Acc 0001144204-13-024461

Director acquired 25,000 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
MATHER CHARLES E IV Director 2013-04-26 Conversion +25,000 $0.40 $10,000 175,569 D
Derivatives
MATHER CHARLES E IV Director 2013-04-26 Conversion · Warrants −25,000 85,000 D
Loading xslF345X03/v342876_4.xml…